Curcumin as a potential therapeutic option for NAFLD and other metabolic diseases: need for establishing the underlying mechanism(s) of action

Hepatol Int. 2019 May;13(3):245-247. doi: 10.1007/s12072-019-09942-7. Epub 2019 Mar 19.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Oral
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Curcumin / pharmacology*
  • Curcumin / therapeutic use
  • Humans
  • Non-alcoholic Fatty Liver Disease / drug therapy*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Curcumin